Advertisement

Isoimmunization and Nonimmune Hydrops Fetalis

  • Michael L. Socol

Abstract

The introduction and proper utilization of Rh immune globulin is a prototype example of the effectiveness of preventive medicine. As a result the incidence of maternal Rhesus sensitization has decreased dramatically. It is therefore not surprising that many obstetricians now find themselves unfamiliar with the pathophysiology and principles of management of blood group isoimmunization.

Keywords

Obstet Gynecol Fetal Heart Rate Anemic Fetus Intrauterine Transfusion Hydropic Fetus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Race RR, Mourant AE, Lawler SD, Sander R. The Rh chromosome frequencies in England. Blood. 1948;3:689–695.PubMedGoogle Scholar
  2. 2.
    Lacey PA, Caskey CR, Werner DJ, Moulds JJ. Fatal hemolytic disease of a newborn due to anti-D in an Rh-positive DU variant mother. Transfusion. 1983;23:91–94.PubMedCrossRefGoogle Scholar
  3. 3.
    Zipursky A, Israels LG. The pathogenesis and prevention of Rh immunization. Can Med Assoc J. 1967;97:1245–1257.PubMedGoogle Scholar
  4. 4.
    Bowman JM. Maternal blood group isoimmunization. In: Creasy RK, Resnik R, eds. Maernal-fetal medicine: Principles and practice. Philadelphia: WB Saunders; 1984:561–602.Google Scholar
  5. 5.
    Woodrow JC. Rh immunization and its prevention. Ser Hematol. 1970;3:34–50.Google Scholar
  6. 6.
    Bowman JM, Chown B, Lewis M, Pollock JM. Rh isoimmunization during pregnancy: Antenatal prophylaxis. Can Med Assoc J. 1978; 118:623–627.PubMedGoogle Scholar
  7. 7.
    Bowman JM, Pollock JM. Antenatal prophylaxis of Rh isoimmunization: 28 weeks’ gestation service program. Can Med Assoc J. 1978;118:627–630.PubMedGoogle Scholar
  8. 8.
    Committee on Technical Bulletins. Prevention of D isoimmunization. Technical Bulletin 147, Washington, DC: American College of Obstertricans and Gynecologists; October 1990.Google Scholar
  9. 9.
    Bowman JM. Suppression of Rh isoimmunization. Obstet Gynecol. 1978;52:385–393.PubMedGoogle Scholar
  10. 10.
    Pollack W, Ascari WQ, Kochesky RJ, O’Connor RR, Ho TY, Tripodi D. Studies on Rh prophylaxis. 1. Relationship between doses of anti-Rh and size of antigenic stimulus. Transfusion. 1971;11:333–339.PubMedCrossRefGoogle Scholar
  11. 11.
    Stedman, CM, Baudin JC, White CW, Cooper ES. Use of the erythrocyte rosette test to screen for excessive fetomaternal hemorrhage in Rh-negative women. Am J Obstet Gynecol. 1986;154:1363–1369.PubMedGoogle Scholar
  12. 12.
    Murray JC, Karl LE, Williamson RA, Cheng EY, Luthy DA. Rh isoimmunization related to amniocentesis. Am J Med Genet. 1983;16:527–534.PubMedCrossRefGoogle Scholar
  13. 13.
    Nicolaides KH, Warenski JC, Rodeck CH. The relationship of fetal plasma protein concentration and hemoglobin level to the development of hydrops in Rhesus isoimmunization. Am J Obstet Gynecol. 1985;152:341–344.PubMedGoogle Scholar
  14. 14.
    Phibbs RH, Johnson P, Tooley W. Cardiorespiratory status of erythroblastotic infants. II. Blood volume, hematocrit and serum albumin concentration in relation to hydrops fetalis. Pediatrics. 1974;53:13–23.PubMedGoogle Scholar
  15. 15.
    Nicolaides KH, Clewell WH, Mibashan RS, Soothill PW, Rodeck CH, Campbell S. Fetal haemoglobin measurement in the assessment of red cell isoimmunization. Lancet. 1988;1:1073–1075.PubMedCrossRefGoogle Scholar
  16. 16.
    Nicolaides KH, Thilaganathan B, Rodeck CH, Mibashan RS. Erythroblastosis and reticulocytosis in anemic fetuses. Am J Obstet Gynecol. 1988;159:1063–1065.PubMedGoogle Scholar
  17. 17.
    Nicolaides KH, Thilaganathan B, Mibashan RS. Cordocentesis in the investigation of fetal erythropoiesis. Am J Obstet Gynecol. 1989; 161:1197–1200.PubMedGoogle Scholar
  18. 18.
    Nicolaides KH. Studies on fetal physiology and pathophysiology in Rhesus disease. Semin Perinatal 1989;13:328–337.Google Scholar
  19. 19.
    Harman CR, Manning FA, Bowman JM, Lange IR. Severe Rh disease—Poor outcome is not inevitable. Am J Obstet Gynecol. 1983;145: 823–829.PubMedGoogle Scholar
  20. 20.
    Weiner CP, Smith F, Robillard JE. Arginine vasopressin (AVP) and acute, intravascular volume expansion in the human fetus. Fetal Ther. 1989;4:69–72.PubMedCrossRefGoogle Scholar
  21. 21.
    Robillard JE, Weiner CP. Atrial natriuretic factor in the human fetus—Effect of volume expansion. J Pediatr. 1988;113:552–555.PubMedCrossRefGoogle Scholar
  22. 22.
    Weiner CP, Heilskov J, Pelzer G, Grant S, Wenstrom K, Williamson RA. Normal values for human umbilical venous and amniotic fluid pressures and their alteration by fetal disease. Am J Obstet Gynecol. 1989;161:714–717.PubMedGoogle Scholar
  23. 23.
    Bowman JM. The management of Rh isoimmunization. Obstet Gynecol. 1978;52:1–16.PubMedGoogle Scholar
  24. 24.
    Chitkara U, Bussel J, Alvarez M, Lynch L, Meisel RL, Berkowitz R. High-dose intravenous gamma globulin: Does it have a role in the treatment of severe erythroblastosis? Obstet Gynecol. 1990;76:703–708.PubMedGoogle Scholar
  25. 25.
    Bowman JM, Pollock JM. Transplacental fetal hemorrhage after amniocentesis. Obstet Gynecol. 1985;66:749–754.PubMedGoogle Scholar
  26. 26.
    Liley AW. Liquor amnii analyses in the management of pregnancy complicated by Rhesus sensitization. Am J Obstet Gynecol. 1961;82: 1359–1370.PubMedGoogle Scholar
  27. 27.
    Nicolaides KH, Rodeck CH, Mibashan RS. Have Liley charts outlived their usefulness? Am J Obstet Gynecol. 1986;155:90–94.PubMedGoogle Scholar
  28. 28.
    Anath U, Queenan JT. Does midtrimester OD450 of amniotic fluid reflect severity of Rh disease? Am J Obstet Gynecol. 1989;161:47–49.Google Scholar
  29. 29.
    Vintzileos AM, Campbell WA, Storlazzi E, Mirochnick MH, Escoto DT, Nochmison DJ. Fetal liver ultrasound measurements in isoimmunized pregnancies. Obstet Gynecol 1986;68:162–167.PubMedGoogle Scholar
  30. 30.
    Roberts AS, Mitchell JM, Pattison NS. Fetal liver length in normal and isoimmunized pregnancies. Am J Obstet Gynecol. 1989;161:42–46.PubMedGoogle Scholar
  31. 31.
    Grannum PA. Ultrasound examination of the placenta. Clin Obstet Gynaecol. 1983;10:459–473.PubMedGoogle Scholar
  32. 32.
    DeVore GR, Donnerstein RL, Kleinman CS, Platt LD, Hobbins JC. Fetal echocardiography. II. The diagnosis and significance of a pericardial effusion in the fetus using real-time-directed M-mode ultrasound. Am J Obstet Gynecol. 1982;144:693–700.PubMedGoogle Scholar
  33. 33.
    Chitkara U, Wilkins I, Lynch L, Mehalek K, Berkowitz R. The role of sonography in assessing severity of fetal anemia in Rh— and Kellisoimmunized pregnancies. Obstet Gynecol. 1988;71:393–398.PubMedGoogle Scholar
  34. 34.
    Benacerraf BR, Frigoletto FD. Sonographic sign for the detection of early fetal ascites in the management of severe isoimmune disease without intrauterine transfusion. Am J Obstet Gynecol. 1985;152:1039–1041.PubMedGoogle Scholar
  35. 35.
    Rightmire DA, Nicolaides KH, Rodeck CH, Campbell S. Fetal blood velocities in Rhesus isoimmunization: Relationship to gestational age and to fetal hematocrit. Obstet Gynecol. 1986;68:233–236.PubMedGoogle Scholar
  36. 36.
    Copel JA, Grannum PA, Green JJ, Belanger K, Hobbins JC. Pulsed Doppler flow-velocity waveforms in the prediction of fetal hematocrit of the severely isoimmunized pregnancy. Am J Obstet Gynecol. 1989;161:341–344.PubMedGoogle Scholar
  37. 37.
    Man G, Moise KJ, Deter RL, Kirshon B, Stefos T, Carpenter RJ. Flow velocity waveforms of the vascular system in the anemic fetus before and after intravascular transfusion for severe red blood cell alloimmunization. Am J Obstet Gynecol. 1990;162:1060–1064.Google Scholar
  38. 38.
    Nicolaides KH, Fontanarosa M, Gabbe SG, Rodeck CH. Failure of ultrasonographic parameters to predict the severity of fetal anemia in Rhesus isoimmunization. Am J Obstet Gynecol. 1988;158:920–926.PubMedGoogle Scholar
  39. 39.
    Rochard F, Schifrin B, Goupil F, Legrand H, Blottiere J, Sureau C. Nonstressed fetal heart rate monitoring in the antepartum period. Am J Obstet Gynecol. 1976;126:699–706.PubMedGoogle Scholar
  40. 40.
    Modanlou HD, Freeman RK, Ortiz O, Hinkes P, Pillsbury G. Sinusoidal fetal heart rate pattern and severe fetal anemia. Obstet Gynecol. 1977;49:537–541.PubMedGoogle Scholar
  41. 41.
    Elliott JP, Modanlou HD, O’Keefe DF, Freeman RK. Significance of fetal and neonatal sinusoidal heart rate pattern: Further clinical observations in Rh incompatibility. Am J Obstet Gynecol. 1980;138:227–230.PubMedGoogle Scholar
  42. 42.
    Nicolaides KH, Sadovsky G, Cetin E. Fetal heart rate patterns in red blood cell isoimmunized pregnancies. Am J Obstet Gynecol. 1989;161:351–356.PubMedGoogle Scholar
  43. 43.
    Socol ML, MacGregor SN, Pielet BW, Tamura RK, Sabbagha RE. Percutaneous umbilical transfusion in severe Rhesus isoimmunization: Resolution of fetal hydrops. Am J Obstet Gynecol. 1987;157:1369–1375.PubMedGoogle Scholar
  44. 44.
    Harman CR, Bowman JM, Manning FA, Menticoglou SM. Intrauterine transfusion— Intraperitoneal versus intravascular approach: A case-control comparison. Am J Obstet Gynecol. 1990;162:1053–1059.PubMedGoogle Scholar
  45. 45.
    Pattison N, Roberts A. The management of severe erythroblastosis fetalis by fetal transfusion: Survival of transfused adult erythrocytes in the fetus. Obstet Gynecol. 1989;74:901–904.PubMedGoogle Scholar
  46. 46.
    Pielet BW, Socol ML, MacGregor SN, Dooley SL, Minogue J. Fetal heart rate changes after intravascular treatment with pancuronium bromide. Am J Obstet Gynecol. 1988;159:640–643.PubMedGoogle Scholar
  47. 47.
    Reece EA, Copel JA, Scioscia AL, Grannum PAT, DeGennaro N, Hobbins JC. Diagnostic fetal umbilical blood sampling in the management of isoimmunization. Am J Obstet Gynecol. 1988;159:1057–1062.PubMedGoogle Scholar
  48. 48.
    Gonsoulin WJ, Moise KJ, Milam JD, Sala JD, Weber VW, Carpenter RJ. Serial maternal blood donations for intrauterine transfusion. Obstet Gynecol. 1990;75:158–162.PubMedGoogle Scholar
  49. 49.
    Rodeck CH, Nicolaides KH, Warsof SL, Fysh WJ, Gamsu HR, Kemp JR. The management of severe Rhesus isoimmunization by fetoscopic intravascular transfusions. Am J Obstet Gynecol. 1984;150:769–774.PubMedGoogle Scholar
  50. 50.
    Morris JA, Hustead RF, Robinson RG, Haswell GL, Morgan CA, Gobuty A. Measurement of fetoplacental blood volume in the human previable fetus. Am J Obstet Gynecol 1973; 118:927–934.Google Scholar
  51. 51.
    Brace RA. Ovine fetal cardiovascular reponses to packed red blood cell transfusions. Am J Obstet Gynecol. 1989;161:1367–1374.PubMedGoogle Scholar
  52. 52.
    Nicolaides KH, Clewell WH, Rodeck CH. Measurement of human fetoplacental blood volume in erythroblastosis fetalis. Am J Obstet Gynecol. 1987;157:50–53.PubMedGoogle Scholar
  53. 53.
    MacGregor SN, Socol ML, Pielet BW, Sholl JT, Minogue JP. Prediction of fetoplacental blood volume in isoimmunized pregnancy. Am J Obstet Gynecol. 1988;159:1493–1497.PubMedGoogle Scholar
  54. 54.
    Plecas DV, Chitkara U, Berkowitz GS, Lapinski RH, Alvarez M, Berkowitz RL. Intrauterine intravascular transfusion for severe erythroblastosis fetalis: How much to transfuse? Obstet Gynecol. 1990;75:965–969.PubMedGoogle Scholar
  55. 55.
    MacGregor, SN, Socol ML, Pielet BW, Sholl J, Silver RK. Prediction of hematocrit decline after intravascular fetal transfusion. Am J Obstet Gynecol. 1989;161:1491–1493.PubMedGoogle Scholar
  56. 56.
    Grannum PA, Copel JA, Plaxe SC, Scioscia AL, Hobbins JC. In utero exchange transfusion by direct intravascular injection in severe erythroblastosis fetalis. N Engl J Med. 1986;314:1431–1434.PubMedCrossRefGoogle Scholar
  57. 57.
    Ney JA, Socol ML, Dooley, SL, MacGregor SN, Silver RK, Millard DD. Perinatal outcome following intravascular transfusion in severely isoimmunized fetuses. Int J Gynecol Obstet. 1991;35:41–46.CrossRefGoogle Scholar
  58. 58.
    Watts DH, Luthy DA, Benedetti TJ, Cyr DR, Easterling TR, Hickok D. Intraperitoneal fetal transfusion under direct ultrasound guidance. Obstet Gynecol. 1988;71:84–88.PubMedGoogle Scholar
  59. 59.
    Frigoletto FD, Umansky I, Birnholz J, Acker D, Easterday CL, Harris GBC, Griscom NT. Intrauterine fetal transfusion in 365 fetuses during fifteen years. Am J Obstet Gynecol. 1981;139:781–790.PubMedGoogle Scholar
  60. 60.
    Berkowitz RL, Chitkara U, Wilkins IA, Lynch L, Plosker H, Bernstein HH. Intravascular monitoring and management of erythroblastosis fetalis. Am J Obstet Gynecol. 1988;158:783–795.PubMedGoogle Scholar
  61. 61.
    Barss VA, Benacerraf BR, Frigoletto FD, et al. Management of isoimmunized pregnancy by use of intravascular techniques. Am J Obstet Gynecol. 1988;159:932–937.PubMedGoogle Scholar
  62. 62.
    Parer JT. Severe Rh isoimmunization—Current methods of in utero diagnosis and treatment. Am J Obstet Gynecol. 1988;158:1323–1329.PubMedGoogle Scholar
  63. 63.
    Grannum PAT, Copel JA, Moya FR, et al. The reversal of hydrops fetalis by intravascular intrauterine transfusion in severe isoimmune fetal anemia. Am J Obstet Gynecol. 1988;158:914–919.PubMedGoogle Scholar
  64. 64.
    Daffos F, Capella-Pavlovsky M, Forestier F. Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: A study of 606 consecutive cases. Am J Obstet Gynecol. 1985;153:655–660.PubMedGoogle Scholar
  65. 65.
    Pielet BW, Socol ML, MacGregor SN, Ney JA, Dooley SL. Cordocentesis: An appraisal of risks. Am J Obstet Gynecol. 1988;159:1497–1500.PubMedGoogle Scholar
  66. 66.
    Nicolini U, Kochenour NK, Green P, Letsky EA, Johnson RD, Contreras M, Rodeck C Consequences of fetomaternal haemorrhage after intrauterine transfusion. Br Med J. 1988;297:1379–1381.CrossRefGoogle Scholar
  67. 67.
    Taslimi MM, Sibai BM, Mason JM, Dacus JV. Immunoglobulin G subclasses and isoimmunized pregnancy outcome. Am J Obstet Gynecol. 1986;154:1327–1332.Google Scholar
  68. 68.
    Weinstein L. Irregular antibodies causing hemolytic disease of the newborn: A continuing medical problem. Clin Obstet Gynecol. 1982; 25:321–332.PubMedCrossRefGoogle Scholar
  69. 69.
    Copel JA, Scioscia A, Grannum PA, Romero R, Reece EA, Hobbins JC. Percutaneous umbilical blood sampling in the management of Kell isoimmunization. Obstet Gynecol. 1986;67: 288–290.PubMedCrossRefGoogle Scholar
  70. 70.
    Berkowitz RL, Beyth Y, Sadovsky E. Death in utero due to Kell sensitization without excessive elevation of the ∆OD450 value in amniotic fluid. Obstet Gynecol. 1982;60:746–749.PubMedGoogle Scholar
  71. 71.
    Levine P, Burnham L, Katzin E, Vogel P. The role of iso-immunization in the pathogenesis of erythroblastosis fetalis. Am J Obstet Gynecol. 1941;42:925–937.Google Scholar
  72. 72.
    Potter EL. Universal edema of fetus unassociated with erythroblastosis. Am J Obstet Gynecol. 1943;46:130–134.Google Scholar
  73. 73.
    Maidman JE, Yeager C, Anderson V, et al. Prenatal diagnosis and managment of nonimmunologic hydrops fetalis. Obstet Gynecol. 1980;56:571–576.PubMedGoogle Scholar
  74. 74.
    Hutchinson AA, Drew JH, Yu VY, Williams ML, Fortune DW, Beischer NA. Nonimmunologic hydrops fetalis: A review of 61 cases. Obstet Gynecol. 1982;59:347–352.Google Scholar
  75. 75.
    Im SS, Rizos N, Joutsi P, Shime J, Benzie RJ. Nonimmunologic hydrops fetalis. Am J Obstet Gynecol. 1984;148:566–569.PubMedGoogle Scholar
  76. 76.
    Holzgreve W, Holzgreve B, Curry CJR. Nonimmune hydrops fetalis: Diagnosis and management. Semin Perinatol. 1985;9:52–67.PubMedGoogle Scholar
  77. 77.
    Jauniaux E, Van Maldergen L, De Munter C, Moscoso G, Gillerot Y. Nonimmune hydrops fetalis associated with genetic abnormalities. Obstet Gynecol. 1990;75:568–572.PubMedGoogle Scholar
  78. 78.
    Holzgreve W, Curry CJR, Golbus MS, Callen PW, Filly RA, Smith JC. Investigation of nonimmune hydrops fetalis. Am J Obstet Gynecol. 1984;150:805–812.PubMedGoogle Scholar
  79. 79.
    Hsieh FJ, Chang FM, Kо TM, Chen HY. Percutaneous ultrasound-guided fetal blood sampling in the management of nonimmune hydrops fetalis. Am J Obstet Gynecol. 1987;157:44–49.PubMedGoogle Scholar
  80. 80.
    Makayama R, Yamada D, Steinmiller V, Hsia E, Hale R. Hydrops fetalis secondary to Bart hemoglobinopathy. Obstet Gynecol. 1986;67: 176–180.CrossRefGoogle Scholar
  81. 81.
    Gehlbach DL, Morgenstern LL. Antenatal screening for thalassemia minor. Obstet Gynecol. 1988;71:801–803.PubMedGoogle Scholar
  82. 82.
    Graves GR, Baskett TF. Nonimmune hydrops fetalis: Antenatal diagnosis and management. Am J Obstet Gynecol. 1984;148:563–565.PubMedGoogle Scholar
  83. 83.
    Watson J, Campbell S. Antenatal evaluation and managment in nonimmune hydrops fetalis. Obstet Gynecol. 1986;67:589–593.PubMedGoogle Scholar
  84. 84.
    Castillo RA, Devoe LD, Hadi HA, Martin S, Geist D. Nonimmune hydrops fetalis: Clinical experience and factors related to a poor outcome. Am J Obstet Gynecol. 1986;155:812–816.PubMedGoogle Scholar
  85. 85.
    Jackson DN, Major C, Lewis D, Gocke S. Improved neonatal survival in nonimmune hydrops. Abstract 9, Society of Perinatal Obstetricians, Houston, Texas, January 23–27,1990.Google Scholar
  86. 86.
    Müller-Flenbach E, Mazer J. Sonographically documented disappearance of fetal ascites. Obstet Gynecol. 1983;61:253–255.Google Scholar
  87. 87.
    Fadel HE, Reudrich DA. Intrauterine resolution of nonimmune hydrops associated with cytomegalovirus infection. Obstet Gynecol. 1988;71:1003–1005.PubMedGoogle Scholar
  88. 88.
    Benacerraf BR, Frigoletto FD. In utero treatment of a fetus with diaphragmatic hernia complicated by hydrops. Am J Obstet Gynecol. 1986;155:817–818.PubMedGoogle Scholar
  89. 89.
    Guntheroth WG, Cyr DR, Mack LA, Benedetti T, Lenke RR, Petty CN. Hydrops from reciprocating atrioventricular tachycardia in a 27-week fetus requiring quinidine for conversion. Obstet Gynecol. 1985;66(suppl):29–33.Google Scholar
  90. 90.
    Weiner C, Varner M, Pringle K, Hein H, Williamson R, Smith WL. Antenatal diagnosis and palliative treatment of non-immune hydrops fetalis secondary to pulmonary extralobar sequestration. Obstet Gynecol. 1986;68: 275–280.PubMedGoogle Scholar
  91. 91.
    Clark SL, Vitale DJ, Minton SD, Stoddard RA, Sabey PL. Successful fetal therapy for cystic adenomatoid malformation associated with second-trimester hydrops. Am J Obstet Gynecol. 1987;157:294–295.PubMedGoogle Scholar
  92. 92.
    Cardwell MS. Successful treatment of hydrops fetalis caused by fetomaternal hemorrhage. A case report. Am J Obstet Gynecol. 1988; 158:131–132.PubMedGoogle Scholar
  93. 93.
    Shimokawa H, Hara K, Fukuda A, Nakano H. Idiopathic hydrops fetalis successfully treated in utero. Obstet Gynecol. 1988;71:984–986.PubMedGoogle Scholar
  94. 94.
    Peters MT, Nicolaides KH. Cordocentesis for the diagnosis and treatment of human fetal parvovirus infection. Obstet Gynecol. 1990,75:501–504.PubMedGoogle Scholar
  95. 95.
    Soothill P. Intrauterine blood transfusion for nonimmune hydrops fetalis due to parvovirus B19 infection. Lancet. 1990;336:121–122.PubMedCrossRefGoogle Scholar
  96. 96.
    Knisely AS. Parvovirus infection in the fetus. Lancet. 1990;336:443.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1993

Authors and Affiliations

  • Michael L. Socol

There are no affiliations available

Personalised recommendations